Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Mar-24 7:02 PM View:  | Ronsheim Matthew See Remarks | Theravance Inc. (INVA) | 05-Mar-24 | Grant | 12,768 | $14.88 | $189,988.00 | 46% 28.01K to 40.78K | |
| 07-Mar-24 7:00 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 05-Mar-24 | Grant | 10,752 | $14.88 | $159,990.00 | 29% 36.81K to 47.57K | |
| 07-Mar-24 7:04 PM View: | Basso Stephen Chief Financial Officer | Theravance Inc. (INVA) | 05-Mar-24 | Grant | 12,096 | $14.88 | $179,988.00 | 100% 0 to 12.1K | |
| 22-Feb-24 9:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Feb-24 | Payment of Exercise | 2,862 | $15.80 | $45,219.60 | (7%) 39.68K to 36.81K | (12%) |
| 22-Feb-24 9:31 PM View: | Ronsheim Matthew See Remarks | Theravance Inc. (INVA) | 20-Feb-24 | Payment of Exercise | 807 | $15.80 | $12,750.60 | (3%) 28.82K to 28.01K | (12%) |
| 22-Jan-24 9:16 PM View: | Ronsheim Matthew See Remarks | Theravance Inc. (INVA) | 18-Jan-24 | Payment of Exercise | 1,600 | $16.05 | $25,680.00 | (5%) 30.42K to 28.82K | (10%) |
| 22-Nov-23 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Nov-23 | Payment of Exercise | 784 | $13.62 | $10,678.10 | (2%) 40.46K to 39.68K | |
| 17-Nov-23 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 15-Nov-23 | Sale | 10,994 | $13.99 | $153,810.00 | (21%) 51.15K to 40.16K | |
| 22-Nov-23 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 15-Nov-23 | Grant | 302 | -- | -- | < 1% 40.16K to 40.46K | |
| 31-Aug-23 1:58 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 18-Aug-23 | Payment of Exercise | 785 | $13.64 | $10,707.40 | (2%) 51.94K to 51.15K | |
| 07-Jun-23 8:10 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 06-Jun-23 | Purchase | 8,000 | $13.05 | $104,384.00 | < 1% 7.21M to 7.21M | |
| 07-Jun-23 8:10 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 05-Jun-23 | Private Purchase | 7,000 | $13.04 | $91,296.80 | < 1% 7.2M to 7.21M | |
| 30-May-23 7:01 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 30-May-23 | Purchase | 120,000 | $13.01 | $1,560,650.00 | 2% 7.08M to 7.2M | |
| 30-May-23 7:01 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 26-May-23 | Purchase | 30,000 | $13.12 | $393,729.00 | < 1% 7.05M to 7.08M | |
| 30-May-23 7:01 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 25-May-23 | Private Purchase | 50,000 | $13.09 | $654,330.00 | < 1% 7.0M to 7.05M | |
| 24-May-23 5:54 PM View: | Schlesinger Sarah J. Director | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 19% 88.21K to 104.71K | |
| 24-May-23 5:56 PM View: | Birx Deborah Director | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 39% 42.49K to 58.98K | |
| 24-May-23 5:53 PM View: | Haimovitz Jules Director | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 16% 100.41K to 116.91K | |
| 24-May-23 5:47 PM View: | Kostas Odysseas D Director | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 18% 92.21K to 108.7K | |
| 24-May-23 5:57 PM View: | Srivastava Sapna Director | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 121% 13.68K to 30.17K | |
| 24-May-23 5:50 PM View: | Dipaolo Mark Director | Theravance Inc. (INVA) | 22-May-23 | Grant | 16,495 | -- | -- | 19% 88.21K to 104.71K | |
| 23-May-23 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-May-23 | Payment of Exercise | 784 | $13.47 | $10,560.50 | (1%) 52.72K to 51.94K | |
| 19-May-23 8:00 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 18-May-23 | Purchase | 10,000 | $13.05 | $130,538.00 | < 1% 6.95M to 6.96M | |
| 19-May-23 8:00 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 17-May-23 | Private Purchase | 50,000 | $13.07 | $653,690.00 | < 1% 6.9M to 6.95M | |
| 23-May-23 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 15-May-23 | Grant | 1,576 | -- | -- | 3% 51.15K to 52.72K | |
| 15-May-23 9:09 PM View: | Denner Alexander J 10% Owner | Theravance Inc. (INVA) | 11-May-23 | Private Purchase | 290,000 | $12.34 | $3,577,410.00 | 4% 6.61M to 6.9M | |
| 17-Apr-23 7:27 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 13-Apr-23 | Grant | 14,344 | -- | -- | 39% 36.8K to 51.15K | |
| 14-Mar-23 5:00 PM View: | Raifeld Pavel Chief Executive Officer | Theravance Inc. (INVA) | 10-Mar-23 | Private Purchase | 3,000 | $10.87 | $32,603.10 | 44% 6.8K to 9.8K | |
| 22-Feb-23 4:31 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 17-Feb-23 | Payment of Exercise | 1,852 | $12.42 | $23,001.80 | (5%) 38.65K to 36.8K | |
| 22-Nov-22 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 18-Nov-22 | Payment of Exercise | 828 | $13.55 | $11,219.40 | (2%) 39.48K to 38.65K | |
| 22-Nov-22 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 15-Nov-22 | Grant | 433 | -- | -- | 1% 39.05K to 39.48K | |
| 22-Aug-22 6:16 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Aug-22 | Payment of Exercise | 830 | $14.12 | $11,719.60 | (2%) 39.88K to 39.05K | |
| 23-May-22 4:31 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-May-22 | Payment of Exercise | 828 | $16.29 | $13,488.10 | (2%) 40.71K to 39.88K | |
| 23-May-22 4:31 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 13-May-22 | Grant | 1,834 | -- | -- | 5% 38.87K to 40.71K | |
| 27-Apr-22 6:53 PM View: | Birx Deborah Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 42% 29.84K to 42.49K | |
| 27-Apr-22 6:51 PM View: | Haimovitz Jules Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 14% 87.76K to 100.41K | |
| 27-Apr-22 6:52 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 10% 124.56K to 137.21K | |
| 27-Apr-22 6:47 PM View: | Kostas Odysseas D Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 16% 79.56K to 92.21K | |
| 27-Apr-22 6:49 PM View: | Dipaolo Mark Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 17% 75.56K to 88.21K | |
| 27-Apr-22 6:48 PM View: | Schlesinger Sarah J. Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 17% 75.56K to 88.21K | |
| 02-Mar-22 8:40 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 01-Mar-22 | Grant | 6,691 | -- | -- | 21% 32.18K to 38.87K | |
| 22-Feb-22 5:06 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 18-Feb-22 | Payment of Exercise | 2,277 | $19.99 | $45,517.20 | (7%) 34.46K to 32.18K | |
| 22-Nov-21 5:01 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Nov-21 | Payment of Exercise | 758 | $17.05 | $12,923.90 | (2%) 35.22K to 34.46K | (< 1%) |
| 23-Aug-21 5:02 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Aug-21 | Payment of Exercise | 760 | $15.94 | $12,114.40 | (2%) 35.36K to 34.6K | 0% |
| 23-Aug-21 5:02 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Aug-21 | Market Sale | 1,129 | $15.89 | $17,939.80 | 3% 34.23K to 35.36K | < 1% |
| 23-Aug-21 5:02 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Aug-21 | Market Sale | 2,802 | $16.02 | $44,888.00 | (7%) 39.3K to 36.49K | < 1% |
| 25-May-21 6:44 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 24-May-21 | Market Purchase | 10,000 | $13.46 | $134,619.00 | 9% 114.56K to 124.56K | < 1% |
| 25-May-21 6:44 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 21-May-21 | Market Purchase | 10,000 | $12.97 | $129,670.00 | 10% 104.56K to 114.56K | 4% |
| 24-May-21 5:19 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-May-21 | Payment of Exercise | 759 | $13.32 | $10,109.90 | (2%) 40.05K to 39.3K | 1% |
| 24-May-21 5:04 PM View: | Glaxosmithkline Plc 10% Owner | Theravance Inc. (INVA) | 20-May-21 | Market Sale | 32,005,300 | $12.25 | $392,064,000.00 | (100%) 32.01M to 0 | (8%) |
